Bariatric Surgery Candidate, Comorbidities and Coexisting Conditions, Nutrient Deficiency, Weight Loss
Conditions
Keywords
RYGB, OAGB, SADI-S, Sleeve gastrectomy
Brief summary
Assess what revisional surgery is superior and provides the best weight loss after primary LSG. What is the occurrence of complications and the nutritional laboratory status? And if the resolution and /or improvement of associated medical problems after the weight loss will occur.
Detailed description
Laparoscopic sleeve gastrectomy (LSG) gained popularity and has become one of the most performed weight loss procedures worldwide. In the long-term follow-up, the literature states that the incidence of gastroesophageal reflux disease (GERD) accounts for 16%, and weight regains accounting for 70% after LSG. These are the two most common complications which can necessitate further surgical intervention. The hypotheses are that laparoscopic conversion from LSG to Single anastomosis duodeno-ileal bypass (SADI-S), Roux-en-Y gastric bypass (RYGB), or one anastomosis gastric bypass (OAGB) will provide a new significant weight loss, improvement in obesity-related health problems and provide no nutritional deficiency in all cases. Since the three types of procedures have other anatomical presentations, whereby these is not well tested next to each other in a blinded, controlled setting for the patient, this study is designed to discover if the procedures are superior to each other or not and what the best outcome is for the patient. A sample size is calculated and with a medium effect size of 0.5 corresponds to a mean difference in %EBMIL between SADI-S, RYGB, and OAGB of at least 10%. Using a power of 0.8 with an alpha of 0.05 resulted in a sample size of 64 patients per group. Considering a possible loss of patients to follow-up, an additional 20% increase in sample size was included per group, resulting in a minimum of 78 patients per group. (Total of 3 groups together of 234 patients).
Interventions
PROCEDURErevision surgery
revision procedure after failed sleeve gastrectomy
Sponsors
General Committee of Teaching Hospitals and Institutes, Egypt
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Intervention model description
A single-blind randomization procedure, in which patients and outpatient clinic nurses will be blinded to the study period p
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes
Inclusion criteria
* Undergone primary laparoscopic sleeve gastrectomy in the past * Weight regain * defined as any increase in weight above the nadir as reported by the patient * BMI at the time of revisional surgery was around 45 kg/m2 * weight regain was defined as an increase in BMI after bariatric surgery to exceed 35 * With or without Gastroesophageal reflux disease (GERD) grade A and B o Patients with grade C or higher GERD, according to the Los Angeles (LA) classification \[7\] will be excluded from the study
Exclusion criteria
* Didn't follow preoperative consultation * Cannot give of sign informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The number of participants who will have early complications related to surgery | 6 weeks | the incidence of re-operation, bleeding or leakages |
| somscore of food tolerance | 2,6 weeks and 3,6,12,24 months | validated food tolerance questions: Food tolerance (FT) was evaluated using a one-page questionnaire divided into 4 sections, 3 of which were used to calculate the score: overall patient satisfaction with eating (score: 1-5); tolerability to certain food types (score: 0-16); and frequency of vomiting/regurgitation (score: 0-6), with a total score between 1 and 27; higher scores indicate better food tolerance |
| The percentage Excess body weight loss (%EWL) | 3,6,12,24 months | the amount of weight loss after revision surgery |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Nutritional levels of albuminemia | 3,6,12,24 months | the albuminemia level will be tested after surgery (g/dl) |
| Nutritional levels of proteinemia | 3,6,12,24 months | the proteinemia level will be tested after surgery (mg/dl) |
| Nutritional levels of anemia | 3,6,12,24 months | the anemia level will be tested after surgery (Mcl) |
| Nutritional levels of calcemic | 3,6,12,24 months | the calcemic level will be tested after surgery (mg/dl) |
| Incidence of Reflux | 3,6,12,24 months | GERD assessment |
| The number of participants who will have late complications related to surgery | 3,6,12,24 months | the incidence of re-operations will be collected |
| Short Form 36 Quality of life | 3,6,12,24 months | Quality of life assessment will be tested 8 chapters with in total 36 questions and a somscore from 0-100 will be calculated (the higher the somscore the better the quality of life is). |
| VAS/NRS (incidence of pain) | 3,6,12,24 months | pain scoring from 0-10 (0 is no pain 10 is most worst pain) |
| Metabolic biomarkers Glucagon-like peptide-1 (GLP1) | 3,6,12,24 months | the GLP1 level will be tested after surgery (mg/ml) |
| Metabolic biomarkers Leptin | 3,6,12,24 months | the Leptin level will be tested after surgery (mg/ml) |
| Metabolic biomarkers Peptide YY ( PYY) | 3,6,12,24 months | the PYY level will be tested after surgery (pg/ml) |
| Metabolic biomarkers Ghrelin | 3,6,12,24 months | the Ghrelin level will be tested after surgery (mg/ml) |
| Metabolic biomarkers Insulin | 3,6,12,24 months | the Insulin level will be tested after surgery (million units/ml) |
Other
| Measure | Time frame | Description |
|---|---|---|
| The number of participants who will have late complications related to surgery | 60 months | the incidence of re-operations or complications will be collected |
| Incidence of Reflux | 60 months | GERD classification |
| The percentage Excess body weight loss (%EWL) | 60 months | the amount of weight loss after revision surgery |
| The number of participants whereby revision surgery necessary after the RCT | 60 months | the incidence of re-operations or other procedure will be collected |
| Nutritional levels of albuminemia | 60 months | the albuminemia level will be tested after surgery (g/dl) |
| Nutritional levels of proteinemia | 60 months | the proteinemia level will be tested after surgery (mg/dl) |
| Nutritional levels of anemia | 60 months | the anemia level will be tested after surgery (Mcl) |
| Nutritional levels of calcemic | 60 months | the calcemic level will be tested after surgery (mg/dl) |
| Somscore of food tolerance | 60 months | validated food tolerance questions: Food tolerance (FT) was evaluated using a one-page questionnaire divided into 4 sections, 3 of which were used to calculate the score: overall patient satisfaction with eating (score: 1-5); tolerability to certain food types (score: 0-16); and frequency of vomiting/regurgitation (score: 0-6), with a total score between 1 and 27; higher scores indicate better food tolerance |
| Short Form 36 Quality of life | 60 months | Quality of life assessment will be tested 8 chapters with in total 36 questions and a somscore from 0-100 will be calculated (the higher the somscore the better the quality of life is). |
| VAS/NRS (incidence of pain) | 60 months | pain scoring from 0-10 (0 is no pain 10 is most worst pain) |
| Metabolic biomarkers Glucagon-like peptide-1 (GLP1) | 60 months | the GLP1 level will be tested after surgery (mg/ml) |
| Metabolic biomarkers Leptin | 60 months | the Leptin level will be tested after surgery (mg/ml) |
| Metabolic biomarkers Peptide YY ( PYY) | 60 months | the PYY level will be tested after surgery (pg/ml) |
| Metabolic biomarkers Ghrelin | 60 months | the Ghrelin level will be tested after surgery (mg/ml) |
| Metabolic biomarkers Insulin | 60 months | the Insulin level will be tested after surgery (million units/ml) |
Countries
Egypt
Contacts
Primary ContactBart Torensma, PHD
Backup ContactMohamed Ashour, MD
Outcome results
None listed